Evolva Holding SA Logo

Evolva Holding SA

EVE.SW

(0.5)
Stock Price

0,91 CHF

-111.33% ROA

-139.43% ROE

-17.29x PER

Market Cap.

4.698.769,00 CHF

14.17% DER

0% Yield

-794.06% NPM

Evolva Holding SA Stock Analysis

Evolva Holding SA Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Evolva Holding SA Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (14%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 ROE

Negative ROE (-35.89%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

3 ROA

The stock's ROA (-111.33%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

4 PBV

The stock's high Price-to-Book Value (P/BV) ratio (36.67x) suggests it's overvalued, potentially making it an expensive investment.

5 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

6 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

7 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Graham Number

The Graham number of this company suggests that its stock price may be overvalued, indicating a less favorable investment opportunity.

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (-84) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Evolva Holding SA Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Evolva Holding SA Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Evolva Holding SA Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Evolva Holding SA Revenue
Year Revenue Growth
2005 0
2006 273.560 100%
2007 164.510 -66.29%
2008 424.404 61.24%
2009 18.926.687 97.76%
2010 18.628.530 -1.6%
2011 11.080.221 -68.12%
2012 7.014.442 -57.96%
2013 8.706.300 19.43%
2014 10.744.300 18.97%
2015 9.399.500 -14.31%
2016 8.747.700 -7.45%
2017 6.846.700 -27.77%
2018 8.932.700 23.35%
2019 11.596.000 22.97%
2020 7.540.700 -53.78%
2021 9.877.600 23.66%
2022 15.539.400 36.44%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Evolva Holding SA Research and Development Expenses
Year Research and Development Expenses Growth
2005 29.199.620
2006 64.703.860 54.87%
2007 44.980.350 -43.85%
2008 43.825.284 -2.64%
2009 21.171.245 -107%
2010 30.949.192 31.59%
2011 0 0%
2012 19.524.405 100%
2013 18.876.000 -3.44%
2014 23.025.500 18.02%
2015 35.019.500 34.25%
2016 33.026.300 -6.04%
2017 28.197.200 -17.13%
2018 18.585.100 -51.72%
2019 13.739.600 -35.27%
2020 13.555.600 -1.36%
2021 22.439.600 39.59%
2022 23.596.800 4.9%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Evolva Holding SA General and Administrative Expenses
Year General and Administrative Expenses Growth
2005 7.271.300
2006 9.186.000 20.84%
2007 15.453.710 40.56%
2008 13.435.880 -15.02%
2009 6.621.857 -102.9%
2010 10.792.286 38.64%
2011 9.521.813 -13.34%
2012 7.543.794 -26.22%
2013 1.184.300 -536.98%
2014 1.974.100 40.01%
2015 2.309.200 14.51%
2016 2.484.500 7.06%
2017 3.717.400 33.17%
2018 5.004.900 25.72%
2019 7.787.700 35.73%
2020 2.654.200 -193.41%
2021 2.575.300 -3.06%
2022 3.110.700 17.21%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Evolva Holding SA EBITDA
Year EBITDA Growth
2005 -33.599.050
2006 -70.638.710 52.44%
2007 -57.249.400 -23.39%
2008 -52.755.588 -8.52%
2009 -6.282.488 -739.72%
2010 -19.142.907 67.18%
2011 -23.459.141 18.4%
2012 -19.411.760 -20.85%
2013 -14.293.300 -35.81%
2014 -19.457.300 26.54%
2015 -28.647.600 32.08%
2016 -33.523.300 14.54%
2017 -38.408.000 12.72%
2018 -25.197.600 -52.43%
2019 -15.875.800 -58.72%
2020 -20.787.400 23.63%
2021 -31.852.100 34.74%
2022 -35.282.400 9.72%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Evolva Holding SA Gross Profit
Year Gross Profit Growth
2005 0
2006 273.560 100%
2007 164.510 -66.29%
2008 424.404 61.24%
2009 18.926.687 97.76%
2010 18.628.530 -1.6%
2011 -16.413.240 213.5%
2012 -12.509.963 -31.2%
2013 -10.169.700 -23.01%
2014 9.620.200 205.71%
2015 7.791.800 -23.47%
2016 5.796.300 -34.43%
2017 2.148.500 -169.78%
2018 2.117.000 -1.49%
2019 5.291.400 59.99%
2020 -2.241.700 336.04%
2021 -9.305.900 75.91%
2022 -6.006.300 -54.94%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Evolva Holding SA Net Profit
Year Net Profit Growth
2005 -35.042.040
2006 -72.530.960 51.69%
2007 -59.120.280 -22.68%
2008 -66.451.549 11.03%
2009 -9.608.907 -591.56%
2010 -23.298.866 58.76%
2011 -22.451.971 -3.77%
2012 -16.089.948 -39.54%
2013 -15.731.900 -2.28%
2014 -21.352.900 26.32%
2015 -31.891.900 33.05%
2016 -35.970.700 11.34%
2017 -38.976.900 7.71%
2018 -29.213.900 -33.42%
2019 -21.638.900 -35.01%
2020 -29.864.200 27.54%
2021 -41.266.400 27.63%
2022 -42.705.700 3.37%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Evolva Holding SA Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2005 -475
2006 -859 44.7%
2007 -616 -39.45%
2008 -591 -4.41%
2009 -28 -2007.14%
2010 -33 12.5%
2011 -28 -14.29%
2012 -18 -55.56%
2013 -14 -38.46%
2014 -15 13.33%
2015 -19 16.67%
2016 -19 0%
2017 -20 10%
2018 -9 -122.22%
2019 0 0%
2020 -9 100%
2021 -12 18.18%
2022 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Evolva Holding SA Free Cashflow
Year Free Cashflow Growth
2005 -36.183.370
2006 -56.097.220 35.5%
2007 -60.260.320 6.91%
2008 -44.630.766 -35.02%
2009 -8.470.303 -426.91%
2010 -17.977.754 52.88%
2011 -18.367.760 2.12%
2012 -14.026.054 -30.95%
2013 -13.504.100 -3.87%
2014 -20.998.500 35.69%
2015 -33.656.800 37.61%
2016 -35.009.400 3.86%
2017 -36.163.200 3.19%
2018 -36.508.300 0.95%
2019 -4.881.775 -647.85%
2020 -28.968.900 83.15%
2021 -33.573.500 13.71%
2022 -21.133.500 -58.86%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Evolva Holding SA Operating Cashflow
Year Operating Cashflow Growth
2005 -34.405.780
2006 -53.947.330 36.22%
2007 -59.087.490 8.7%
2008 -44.535.168 -32.68%
2009 -5.933.657 -650.55%
2010 -15.831.343 62.52%
2011 -17.402.435 9.03%
2012 -13.445.766 -29.43%
2013 -12.523.800 -7.36%
2014 -19.797.200 36.74%
2015 -31.792.200 37.73%
2016 -33.852.300 6.09%
2017 -35.572.900 4.84%
2018 -23.607.000 -50.69%
2019 -3.540.125 -566.84%
2020 -23.362.700 84.85%
2021 -29.789.200 21.57%
2022 -18.880.700 -57.78%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Evolva Holding SA Capital Expenditure
Year Capital Expenditure Growth
2005 1.777.590
2006 2.149.890 17.32%
2007 1.172.830 -83.31%
2008 95.598 -1126.84%
2009 2.536.646 96.23%
2010 2.146.411 -18.18%
2011 965.325 -122.35%
2012 580.288 -66.35%
2013 980.300 40.81%
2014 1.201.300 18.4%
2015 1.864.600 35.57%
2016 1.157.100 -61.14%
2017 590.300 -96.02%
2018 12.901.300 95.42%
2019 1.341.650 -861.6%
2020 5.606.200 76.07%
2021 3.784.300 -48.14%
2022 2.252.800 -67.98%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Evolva Holding SA Equity
Year Equity Growth
2005 130.878.470
2006 65.476.830 -99.89%
2007 67.122.540 2.45%
2008 21.861.937 -207.03%
2009 67.569.354 67.65%
2010 51.918.516 -30.15%
2011 72.679.385 28.57%
2012 61.261.047 -18.64%
2013 80.703.700 24.09%
2014 173.175.600 53.4%
2015 201.611.100 14.1%
2016 171.131.300 -17.81%
2017 220.720.800 22.47%
2018 194.161.700 -13.68%
2019 172.562.100 -12.52%
2020 145.092.100 -18.93%
2021 131.770.200 -10.11%
2022 106.239.000 -24.03%
2023 28.816.400 -268.68%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Evolva Holding SA Assets
Year Assets Growth
2005 135.652.840
2006 83.753.780 -61.97%
2007 86.529.290 3.21%
2008 44.355.237 -95.08%
2009 92.896.955 52.25%
2010 75.024.378 -23.82%
2011 106.495.327 29.55%
2012 90.372.760 -17.84%
2013 105.272.400 14.15%
2014 212.611.600 50.49%
2015 232.236.600 8.45%
2016 198.235.500 -17.15%
2017 239.821.800 17.34%
2018 213.017.000 -12.58%
2019 192.078.100 -10.9%
2020 166.892.900 -15.09%
2021 156.173.400 -6.86%
2022 131.007.300 -19.21%
2023 53.137.000 -146.55%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Evolva Holding SA Liabilities
Year Liabilities Growth
2005 4.774.710
2006 18.276.970 73.88%
2007 19.406.760 5.82%
2008 22.493.300 13.72%
2009 24.962.204 9.89%
2010 22.054.673 -13.18%
2011 33.274.672 33.72%
2012 29.134.062 -14.21%
2013 21.991.200 -32.48%
2014 37.617.900 41.54%
2015 28.821.000 -30.52%
2016 25.178.900 -14.46%
2017 19.101.000 -31.82%
2018 18.855.300 -1.3%
2019 19.516.000 3.39%
2020 21.800.800 10.48%
2021 24.403.200 10.66%
2022 24.768.300 1.47%
2023 24.320.600 -1.84%

Evolva Holding SA Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.01
Net Income per Share
-0.04
Price to Earning Ratio
-17.29x
Price To Sales Ratio
0.3x
POCF Ratio
-39.11
PFCF Ratio
-0.22
Price to Book Ratio
6.95
EV to Sales
0.94
EV Over EBITDA
-0.41
EV to Operating CashFlow
-0.77
EV to FreeCashFlow
-0.69
Earnings Yield
-0.06
FreeCashFlow Yield
-4.5
Market Cap
0,00 Bil.
Enterprise Value
0,01 Bil.
Graham Number
0.3
Graham NetNet
-0.01

Income Statement Metrics

Net Income per Share
-0.04
Income Quality
0.44
ROE
-0.36
Return On Assets
-1.77
Return On Capital Employed
-0.56
Net Income per EBT
1
EBT Per Ebit
4.88
Ebit per Revenue
-1.63
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
0.2
Research & Developement to Revenue
1.52
Stock Based Compensation to Revenue
0.08
Gross Profit Margin
-0.53
Operating Profit Margin
-1.63
Pretax Profit Margin
-7.94
Net Profit Margin
-7.94

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.02
Free CashFlow per Share
-0.02
Capex to Operating CashFlow
0.12
Capex to Revenue
-0.14
Capex to Depreciation
-0.28
Return on Invested Capital
-0.32
Return on Tangible Assets
-1.11
Days Sales Outstanding
111.25
Days Payables Outstanding
71.53
Days of Inventory on Hand
311.57
Receivables Turnover
3.28
Payables Turnover
5.1
Inventory Turnover
1.17
Capex per Share
-0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,10
Tangible Book Value per Share
0.01
Shareholders Equity per Share
0.1
Interest Debt per Share
0.01
Debt to Equity
0.14
Debt to Assets
0.11
Net Debt to EBITDA
-0.28
Current Ratio
1.61
Tangible Asset Value
0,01 Bil.
Net Current Asset Value
0,01 Bil.
Invested Capital
0.14
Working Capital
0,01 Bil.
Intangibles to Total Assets
0.71
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
17330450
Debt to Market Cap
3.2

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Evolva Holding SA Dividends
Year Dividends Growth

Evolva Holding SA Profile

About Evolva Holding SA

Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. It offers various ingredients comprising Veri-te Resveratrol, a nature-made polyphenol that occurs naturally in grapes and other plants, including peanuts, cranberries, and berries; L-Arabinose, a flavoring agent used in Maillard reaction; Valencene, an aroma component of citrus fruit and citrus-derived odorants; Nootkatone, an aroma ingredient of grapefruit obtained via biochemical oxidation of valencene; and Vanillin, a primary component of vanilla bean extract. The company was founded in 2004 and is headquartered in Reinach, Switzerland.

CEO
Mr. Christian Wichert
Employee
49
Address
Duggingerstrasse 23
Reinach, 4153

Evolva Holding SA Executives & BODs

Evolva Holding SA Executives & BODs
# Name Age
1 Mr. Carsten Daweritz
Chief Financial Officer
70
2 Thomas Schneckenburger C.F.A., Ph.D.
Head of Investor & Corporate Relations
70
3 Ms. Anne De Vos
Chief Commercial Officer
70
4 Ms. Astrid Schafer
Head of Research & Development
70
5 Philipp Frech
General Counsel & Secretary of the Board
70
6 Dr. Luc Gruner
Executive Officer
70
7 Mr. Gerhard Lobmaier
Chief Operations Officer
70
8 Mr. Christian Wichert
Chief Executive Officer
70

Evolva Holding SA Competitors